TD Waterhouse Canada’s CONMED CNMD Stock Holding History

TD Waterhouse Canada’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-150	Closed	-$8.11K	–	2080
2025 Q2	$8.11K	Buy	+150	New	+$8.23K	﹤0.01%	1503

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

TD Waterhouse Canada's CNMD Position: Q3 2025 in Review

TD Waterhouse Canada sold out of CONMED (CNMD) in Q3 2025, closing a stake of 150 shares — an estimated $8.11K sold.

TD Waterhouse Canada first reported a position in CNMD in Q2 2025 and held it in 1 quarter. The position peaked at $8.11K in Q2 2025. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

TD Waterhouse Canada reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
TD Waterhouse Canada sold 150 CONMED shares in Q3 2025, an estimated $8.11K.
TD Waterhouse Canada first reported a position in CONMED in Q2 2025 and held it in 1 quarter.
TD Waterhouse Canada's CONMED position peaked at $8.11K in Q2 2025.
273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on TD Waterhouse Canada's 13F filing for Q3 2025, filed 3 Nov 2025.